Case report: Fatal hepatic failure after aortic valve replacement and sevoflurane exposure

Canadian Journal of Anesthesia

Volumn 54, Issue 11, 2007, Pages 917-921

  Lehmann, Andreas ^a   Neher, Michael ^a   Kiessling, Arndt Holger ^a   Isgro, Frank ^a   Koloska, Anette ^a   Boldt, Joachim ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FLUNITRAZEPAM; MIDAZOLAM; NORADRENALIN; PROPOFOL; SEVOFLURANE; SUFENTANIL;

AGED; ANAMNESIS; ANGIOGRAPHY; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CASE REPORT; FEMALE; HUMAN; INTENSIVE CARE; LIVER FAILURE; LOW DRUG DOSE; LYMPHADENECTOMY; PRIORITY JOURNAL;

EID: 36749083561     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03026797     Document Type: Article

References (23)

1. nd, Reed GF, Martin JL. Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg 1997; 84: 173-8.
2. Martin JL. Volatile anesthestics and liver injury: a clinical update or what every anesthesiologist should know. Can J Anesth 2005; 52: 125-9.
3. D'Ancona G, Baillot R, Poirier B, et al. Determinants of gastrointestinal complications in cardiac surgery. Tex Heart Inst J 2003; 30: 280-5.
4. Hagley MT, Hulisz DT, Burns CM. Hepatotoxicity associated with angiotensin-converting enzyme inhibitors. Ann Pharmacother 1993; 27: 228-31.
5. Ray DC, Drummond GB. Halothane hepatitis. Br J Anaesth 1991; 67: 84-99.
6. Nelson PD, Ferguson CN, Jones RM. Anaesthetic organ toxicity: is it really a problem? Curr Opin Anaesthesiol 1998; 11: 399-401.
7. Kharasch ED. Metabolism and toxicity of the new anesthetic agents. Acta Anaesthesiol Belg 1996; 47: 7-14.
8. Tung D, Yoshida EM, Wang CS, Steinbrecher UP. Severe desflurane hepatotoxicity after colon surgery in an elderly patient. Can J Anesth 2005; 52: 133-6.
9. Hasan F. Isoflurane hepatotoxicity in a patient with a previous history of halothane-induced hepatitis. Hepatogastroenterology 1998; 45: 518-22.
10. Christ DD, Satoh H, Kenna JG, Pohl LR. Potential metabolic basis for enflurane hepatitis and the apparent cross-sensitization between enflurane and halothane. Drug Metab Dispos 1988; 16: 135-40.
11. Kharasch ED. Biotransformation of sevoflurane. Anesth Analg 1995; 81(6 Suppl): S27-38.
12. Jang Y, Kim I. Severe hepatotoxicity after sevoflurane anesthesia in a child with mild renal dysfunction. Paediatr Anaesth 2005; 15: 1140-4.
13. Reich A, Everding AS, Bulla M, Brinkmann OA, Vein Aken H. Hepatitis after sevoflurane exposure in an infant suffering from primary hyperoxaluria type 1. Anesth Analg 2004; 99: 370-2.
14. Bruun LS, Elkjaer S, Bitsch-Larsen D, Andersen O. Hepatic failure in a child after acetaminophen and sevoflurane exposure. Anesth Analg 2001; 92: 1446-8.
15. Ogawa M, Doi K, Mitsufuji T, Satoh K, Takatori T. Drug induced hepatitis following sevoflurane anesthesia in a child (Japanese). Masui 1991; 40: 1542-5.
16. Shichinohe Y, Masuda Y, Takahashi H, et al. A case of postoperative hepatic injury after sevoflurane anesthesia (Japanese). Masui 1992; 41: 1802-5.
17. Ohmori H, Seki S, Kanaya N, et al. A case report of postoperative liver dysfunction following sevoflurane anesthesia after isoflurane anesthesia. J Jpn Soc Clin Anesth 1994; 14: 68-71.
18. Watanabe K, Hatakenaka S, Ikemune K, Chigyo Y, Kubozono T, Arai T. A case of suspected liver dysfunction induced by sevoflurane anesthesia (Japanese). Masui 1993; 42: 902-5.
19. Fee JP, Thompson GH. Comparative tolerability profiles of the inhaled anaesthetics. Drug Saf 1997; 16: 157-70.
20. Kharasch ED, Powers KM, Artru AA. Comparison of Amsorb, sodalime, and Baralyme degradation of volatile anesthetics and formation of carbon monoxide and compound A in swine in vivo. Anesthesiology 2002; 96: 173-82.
21. Kharasch ED, Schroeder JL, Sheffels P, Liggitt HD. Influence of sevoflurane on the metabolism and renal effects of compound A in rats. Anesthesiology 2005; 103: 1183-8.
22. Zheng XH, Begay C, Lind RC, Gandolfi AJ. Humoral immune response to a sevoflurane degradation product in the guinea pig following inhalation exposure. Drug Chem Toxicol 2001; 24: 339-46.
23. Chen M, Gandolfi J. Characterization of the humoral immune response and hepatotoxicity after multiple halothane exposures in guinea pigs. Drug Metab Rev 1997; 29: 103-22.